CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine.
Sonbol MB, Ahn DH, Goldstein D, Okusaka T, Tabernero J, Macarulla T, Reni M, Li CP, O'Neil B, Van Cutsem E, Bekaii-Saab T.
Sonbol MB, et al. Among authors: okusaka t.
Future Oncol. 2019 Apr;15(12):1295-1302. doi: 10.2217/fon-2018-0903. Epub 2019 Feb 15.
Future Oncol. 2019.
PMID: 30768369